November 23, 2020
Slideshow
As the countdown to the new year slowly dwindles down, remember the things you can be thankful for in 2020, as hard as it may have been.
September 19, 2019
Article
In this video segment, Dr. Peter Buckley addresses 2 questions: • What factors do you consider when you offer depot medications to a patient with schizophrenia? • What can be done to encourage the use of depot medications?
February 28, 2019
Article
Peter F. Buckley, MD introduces part 1 of our Special Report on schizophrenia.
May 16, 2016
Article
The personalized medicine approach is predicated upon a greater understanding of the biology of illness and how it plays out-uniquely and specifically-for each individual patient.
June 29, 2015
Article
The author of this book tells the story of the evolution of psychiatry from a place of skepticism and distain to its more recent emergence as a modern neuroscience.
September 06, 2012
Article
Has any progress been made in our ability to manage negative symptoms of schizophrenia?
August 29, 2012
Article
In schizophrenia therapy, the question arises whether a patient with hyper-religiosity as a main symptom can be treated with an antipsychotic (like clozapine) that targets that symptom.
August 21, 2012
Article
What effect has the new antipsychotic Latuda had in patients with psychosis? Is a mood stabilizer as an adjunctive therapy necessary for schizophrenia or is the use of an antipsychotic alone sufficient?
July 06, 2012
Article
Weight gain is a known side effect of some medications for schizophrenia. Here: strategies to prevent and manage weight gain.
June 29, 2012
Article
In schizophrenia therapy, perphenazine can play in combating symptoms and in preventing relapse, though it can be associated with metabolic side effects.